Sigilon Therapeutics (SGTX) PT Lowered to $9 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SGTX Hot Sheet
Price: $22.47 --0%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Sigilon Therapeutics (NASDAQ: SGTX) to $9.00 (from $45.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Macquarie Upgrades Merdeka Gold Resources (EMAS:IJ) to Neutral
- Macquarie Upgrades Merdeka Copper Gold Tbk PT (MDKA:IJ) to Outperform
- PT Vale Indonesia Tbk (INCO:IJ) (PTNDF) PT Lowered to IDR5,600 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
